{"id":21546,"date":"2024-10-25T13:51:56","date_gmt":"2024-10-25T17:51:56","guid":{"rendered":"https:\/\/arsacs.com\/?p=21546"},"modified":"2026-03-16T18:16:57","modified_gmt":"2026-03-16T22:16:57","slug":"1-14-millions-pour-un-projet-de-therapie-genique-visant-a-traiter-des-troubles-neurologiques-rares","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/1-14m-for-gene-therapy-project-for-rare-neurological-disorders\/","title":{"rendered":"$1.14M : projet de th\u00e9rapie g\u00e9nique consacr\u00e9 aux maladies neurologiques rares"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Un projet de th\u00e9rapie g\u00e9nique b\u00e9n\u00e9ficie d'une subvention de $1,14 M de la part des Instituts de recherche en sant\u00e9 du Canada (IRSC). Ce projet sera dirig\u00e9 par le Dr Carl Ernst, du Neuro \u00e0 Montr\u00e9al. Sonia Gobeil, cofondatrice de la Fondation Ataxie Charlevoix-Saguenay, apportera le point de vue des familles \u00e0 l'\u00e9quipe de chercheurs. <em> \u00ab Cette subvention va vraiment nous aider \u00e0 aller de l'avant en mettant en place de nouvelles m\u00e9thodes permettant de fournir plus rapidement des traitements aux patients atteints de maladies rares. \u00bb  <\/em>d\u00e9clare le Dr Ernst. <a href=\"https:\/\/arsacs.com\/wp-content\/uploads\/2024\/10\/Press-Release-Gene-therapy-and-ARSACS.pdf\">Annonce.<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>A Gene Therapy project receives $1.14M from the Canadian Institutes of Heath Research (CIHR). The project will be led by Dr. Carl Ernst from the Neuro in Montreal. Sonia Gobeil, co-founder of the Ataxia Charlevoix- Saguenay Foundation, will provide the family perspective for the researcher team. &#8220;This grant will really help us move forward with [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":21557,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-21546","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/21546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=21546"}],"version-history":[{"count":7,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/21546\/revisions"}],"predecessor-version":[{"id":25031,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/21546\/revisions\/25031"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media\/21557"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=21546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=21546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=21546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}